(S)-N-((3-(2-fluoro-4'-(morpholine-4-carbonyl)-[1,1'-biphenyl]-4-yl)-2-oxooxazolidin-5-yl)methyl)acetamide

ID: ALA4538782

PubChem CID: 155549221

Max Phase: Preclinical

Molecular Formula: C23H24FN3O5

Molecular Weight: 441.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(C(=O)N4CCOCC4)cc3)c(F)c2)C(=O)O1

Standard InChI:  InChI=1S/C23H24FN3O5/c1-15(28)25-13-19-14-27(23(30)32-19)18-6-7-20(21(24)12-18)16-2-4-17(5-3-16)22(29)26-8-10-31-11-9-26/h2-7,12,19H,8-11,13-14H2,1H3,(H,25,28)/t19-/m0/s1

Standard InChI Key:  YFLLEXSXVBAZJQ-IBGZPJMESA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   20.6732   -5.0119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4886   -5.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8956   -4.3085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4882   -3.6024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6696   -3.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2664   -4.3103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7090   -4.3062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1168   -5.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9332   -5.0162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3428   -4.3081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9300   -3.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1149   -3.6008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1582   -4.3079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.6393   -4.9684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4162   -4.7151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4153   -3.8978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6378   -3.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3844   -2.8694    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0778   -5.1947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8240   -4.8615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4857   -5.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2319   -5.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4011   -6.1539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7045   -2.8942    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.4492   -4.3128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0385   -3.6063    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0460   -5.0220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2279   -5.0225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8215   -5.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2287   -6.4362    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0468   -6.4357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4578   -5.7264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 10 13  1  0
 17 18  2  0
 15 19  1  1
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 12 24  1  0
  6 25  1  0
 25 26  2  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 25 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4538782

    ---

Associated Targets(non-human)

Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecalis (29875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 441.46Molecular Weight (Monoisotopic): 441.1700AlogP: 2.43#Rotatable Bonds: 5
Polar Surface Area: 88.18Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.47CX LogD: 1.47
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.77Np Likeness Score: -1.51

References

1. Xu S, Jiang J, Qi Y, Ding X, Wu Y, Lei H, Zhao Y..  (2019)  Design and synthesis of biaryloxazolidinone derivatives containing amide or acrylamide moiety as novel antibacterial agents against Gram-positive bacteria.,  29  (23): [PMID:31668973] [10.1016/j.bmcl.2019.126747]

Source